DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
XENON XE 133
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
XENON XE 133
×
Maximum Phase:
4
First Approval:
None
UNII:
X3P9A5HNYF
Molecule Type:
Small molecule
Molecular Formula:
Xe
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LYSINE ACETYLSALICYLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LYSINE ACETYLSALICYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENOLPHTHALEIN
4
Small molecule
Approved
Unknown
Unknown
Constipation
Laxative
PHENOLPHTHALEIN
×
Maximum Phase:
4
First Approval:
None
UNII:
6QK969R2IF
Molecule Type:
Small molecule
Molecular Formula:
C20H14O4
Molecular Weight:
318.33
AlogP:
3.56
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PRENYLAMINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Calmodulin inhibitor
PRENYLAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
K2OH82Z000
Molecule Type:
Small molecule
Molecular Formula:
C24H27N
Molecular Weight:
329.49
AlogP:
5.43
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ALMASILATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ALMASILATE
×
Maximum Phase:
4
First Approval:
None
UNII:
OZQ8O62H53
Molecule Type:
Small molecule
Molecular Formula:
H2Al2MgO13Si4
Molecular Weight:
400.62
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHLOROBUTANOL
4
Small molecule
Approved
Unknown
Unknown
Nausea
Unknown
CHLOROBUTANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
HM4YQM8WRC
Molecule Type:
Small molecule
Molecular Formula:
C4H7Cl3O
Molecular Weight:
177.46
AlogP:
2.13
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ESTRIOL
4
Small molecule
Approved
Unknown
Unknown
Pregnancy; Menopause; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Atrophic Vaginitis
Estrogen receptor modulator
ESTRIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
FB33469R8E
Molecule Type:
Small molecule
Molecular Formula:
C18H24O3
Molecular Weight:
288.39
AlogP:
2.58
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
0.0
Source:
DOPEXAMINE
4
Small molecule
Approved
Unknown
Unknown
Shock, Septic; Cardiovascular Diseases
Unknown
DOPEXAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
398E7Z7JB5
Molecule Type:
Small molecule
Molecular Formula:
C22H32N2O2
Molecular Weight:
356.51
AlogP:
3.62
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
13.0
Source:
MANDELIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MANDELIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
NH496X0UJX
Molecule Type:
Small molecule
Molecular Formula:
C8H8O3
Molecular Weight:
152.15
AlogP:
0.8
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
2.0
Source:
HUPERZINE A
4
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Substance-Related Disorders; Alzheimer Disease; Brain Injuries
Acetylcholinesterase inhibitor
HUPERZINE A
×
Maximum Phase:
4
First Approval:
None
UNII:
0111871I23
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
2.0
PSA:
58.88
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ETOGLUCID
4
Small molecule
Approved
Unknown
Unknown
Neoplasms
DNA cross-linking agent
ETOGLUCID
×
Maximum Phase:
4
First Approval:
None
UNII:
4F9KUA0T4D
Molecule Type:
Small molecule
Molecular Formula:
C12H22O6
Molecular Weight:
262.3
AlogP:
-0.15
PSA:
61.98
HBD:
0.0
HBA:
#RotB:
13.0
Source:
ERGONOVINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ERGONOVINE
×
Maximum Phase:
4
First Approval:
None
UNII:
WH41D8433D
Molecule Type:
Small molecule
Molecular Formula:
C19H23N3O2
Molecular Weight:
325.41
AlogP:
1.53
PSA:
68.36
HBD:
3.0
HBA:
#RotB:
3.0
Source:
PEFLOXACIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial DNA gyrase inhibitor
PEFLOXACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
2H52Z9F2Q5
Molecule Type:
Small molecule
Molecular Formula:
C17H20FN3O3
Molecular Weight:
333.36
AlogP:
1.61
PSA:
65.78
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BOSUTINIB MONOHYDRATE
4
Small molecule
Approved
CANCER; HEMATOLOGY; OTHER
ORAL
Leukemia, Myeloid, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid
Bcr/Abl fusion protein inhibitor
BOSUTINIB MONOHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
C26H31Cl2N5O4
Molecular Weight:
548.47
AlogP:
5.19
PSA:
82.88
HBD:
1.0
HBA:
#RotB:
9.0
Source:
DROTAVERINE
4
Small molecule
Approved
Unknown
Unknown
Bile Duct Diseases; Digestive System Diseases
Phosphodiesterase 4 inhibitor
DROTAVERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
98QS4N58TW
Molecule Type:
Small molecule
Molecular Formula:
C24H31NO4
Molecular Weight:
397.52
AlogP:
4.93
PSA:
48.95
HBD:
1.0
HBA:
#RotB:
9.0
Source:
ETHYL CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Tendon Entrapment
Unknown
ETHYL CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
46U771ERWK
Molecule Type:
Small molecule
Molecular Formula:
C2H5Cl
Molecular Weight:
64.52
AlogP:
1.25
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
0.0
Source:
NAFAMOSTAT
4
Small molecule
Approved
Unknown
Unknown
Acute Kidney Injury; Severe Acute Respiratory Syndrome
Unknown
NAFAMOSTAT
×
Maximum Phase:
4
First Approval:
None
UNII:
Y25LQ0H97D
Molecule Type:
Small molecule
Molecular Formula:
C19H17N5O2
Molecular Weight:
347.38
AlogP:
2.65
PSA:
138.07
HBD:
5.0
HBA:
#RotB:
4.0
Source:
ZINC OLEATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ZINC OLEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
7C247FL5FG
Molecule Type:
Small molecule
Molecular Formula:
C36H66O4Zn
Molecular Weight:
628.31
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CHLORQUINALDOL
4
Small molecule
Approved
Unknown
Unknown
Amebiasis
Unknown
CHLORQUINALDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
D6VHC87LLS
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2NO
Molecular Weight:
228.08
AlogP:
3.56
PSA:
33.12
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ANAGESTONE ACETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ANAGESTONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
GNT396G9QT
Molecule Type:
Small molecule
Molecular Formula:
C24H36O3
Molecular Weight:
372.55
AlogP:
5.48
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
LORNOXICAM
4
Small molecule
Approved
Unknown
Unknown
Alzheimer Disease; Migraine Disorders; Pain; Rheumatic Diseases
Cyclooxygenase inhibitor
LORNOXICAM
×
Maximum Phase:
4
First Approval:
None
UNII:
ER09126G7A
Molecule Type:
Small molecule
Molecular Formula:
C13H10ClN3O4S2
Molecular Weight:
371.83
AlogP:
2.3
PSA:
99.6
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IOBENGUANE SULFATE I-123
4
Small molecule
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
IOBENGUANE SULFATE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BARBITAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BARBITAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
275L5M93QS
Molecule Type:
Small molecule
Molecular Formula:
C8H11N2NaO3
Molecular Weight:
206.18
AlogP:
0.16
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BENPERIDOL
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Dopamine D2 receptor antagonist
BENPERIDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
97O6X78C53
Molecule Type:
Small molecule
Molecular Formula:
C22H24FN3O2
Molecular Weight:
381.45
AlogP:
4.18
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IODOHIPPURATE SODIUM I 131
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IODOHIPPURATE SODIUM I 131
×
Maximum Phase:
4
First Approval:
None
UNII:
9BRV734R3E
Molecule Type:
Small molecule
Molecular Formula:
C9H7INNaO3
Molecular Weight:
331.06
AlogP:
1.11
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
3.0
Source:
QUINFAMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
QUINFAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
O1ZB1046R1
Molecule Type:
Small molecule
Molecular Formula:
C16H13Cl2NO4
Molecular Weight:
354.19
AlogP:
3.58
PSA:
59.75
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MAGALDRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MAGALDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
6V88E24N5T
Molecule Type:
Small molecule
Molecular Formula:
H31Al5Mg10O39S2
Molecular Weight:
1097.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HALQUINOLS
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
HALQUINOLS
×
Maximum Phase:
4
First Approval:
None
UNII:
Z7Z4BX535U
Molecule Type:
Small molecule
Molecular Formula:
C27H17Cl4N3O3
Molecular Weight:
573.26
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ETILEFRINE
4
Small molecule
Approved
Unknown
Unknown
Ascites; Cardiovascular Diseases
Unknown
ETILEFRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
ZB6F8MY53V
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO2
Molecular Weight:
181.24
AlogP:
1.04
PSA:
52.49
HBD:
3.0
HBA:
#RotB:
4.0
Source:
HYDROXOCOBALAMIN
4
Small molecule
Approved
OTHER
INJECTION
Carcinoma, Non-Small-Cell Lung; Colitis, Ulcerative; Keratoconus; Prognathism; Shock, Septic; Syndrome; Cataract; Acne Vulgaris; Anemia; Poisoning
Cyanide sequestering agent
HYDROXOCOBALAMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Q40X8H422O
Molecule Type:
Small molecule
Molecular Formula:
C62H89CoN13O15P
Molecular Weight:
1346.38
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RILMENIDINE
4
Small molecule
Approved
Unknown
Unknown
Hypertension
Nischarin agonist
RILMENIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
P67IM25ID8
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O
Molecular Weight:
180.25
AlogP:
1.15
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
NICORANDIL
4
Small molecule
Approved
Unknown
Unknown
Cognitive Dysfunction; Coronary Disease; Dementia; Premature Birth; Radiation Pneumonitis; Myocardial Infarction; Severe Acute Respiratory Syndrome; Cardiovascular Diseases
Unknown
NICORANDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
260456HAM0
Molecule Type:
Small molecule
Molecular Formula:
C8H9N3O4
Molecular Weight:
211.18
AlogP:
0.02
PSA:
94.36
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BUTAMBEN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Transient receptor potential cation channel subfamily A member 1 inhibitor
BUTAMBEN
×
Maximum Phase:
4
First Approval:
None
UNII:
EFW857872Q
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO2
Molecular Weight:
193.25
AlogP:
2.23
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEVOSIMENDAN
4
Small molecule
Approved
Unknown
Unknown
Acute Kidney Injury; Coronary Disease; Heart Diseases; Hemorrhage; Hernias, Diaphragmatic, Congenital; Ischemic Attack, Transient; Muscular Diseases; Shock, Septic; Stroke; Amyotrophic Lateral Sclerosis; Cardiovascular Diseases; Heart Failure; Severe Acute Respiratory Syndrome; Shock; ST Elevation Myocardial Infarction
Phosphodiesterase 3 inhibitor
LEVOSIMENDAN
×
Maximum Phase:
4
First Approval:
None
UNII:
C6T4514L4E
Molecule Type:
Small molecule
Molecular Formula:
C14H12N6O
Molecular Weight:
280.29
AlogP:
1.36
PSA:
113.43
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PROMESTRIENE
4
Small molecule
Approved
Unknown
Unknown
Hypospadias
Unknown
PROMESTRIENE
×
Maximum Phase:
4
First Approval:
None
UNII:
GXM4PER6WZ
Molecule Type:
Small molecule
Molecular Formula:
C22H32O2
Molecular Weight:
328.5
AlogP:
5.35
PSA:
18.46
HBD:
0.0
HBA:
#RotB:
4.0
Source:
1
2
…
171
172
173
174
175
176
177
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA